SUM 102
Alternative Names: Ad6-MSP-1; SUM-102Latest Information Update: 03 Nov 2023
At a glance
- Originator Sumaya Biotech
- Class Malaria vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Malaria
Most Recent Events
- 12 Sep 2023 Preclinical trials in Malaria (Prevention) in Germany (Parenteral) (Sumaya Biotech pipeline, September 2023)